PTRK 📈 Physitrack - Overview

Exchange: ST • Country: United Kingdom • Currency: SEK • Type: Common Stock • ISIN: GB00BK80TJ35

PTRK: Telehealth, Exercise, Education, Patient, Engagement, Rehabilitation, Software

Physitrack PLC, together with its subsidiaries, provides digital healthcare services in the United Kingdom, Europe, North America, and internationally. The company offers solutions for patient engagement comprising clinical home exercise and education prescription, outcome data gathering, and Telehealth for physical rehabilitation and prevention. It also provides Physitrack app for private practices, occupational health and case management, healthcare systems and hospitals, and elite sports. In addition, the company offers PhysiApp for patients to follow exercise videos and report back on their progress, online and offline. Physitrack PLC was incorporated in 2012 and is based in London, the United Kingdom. Web URL: https://www.physitrack.com

Additional Sources for PTRK Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

PTRK Stock Overview

Market Cap in USD 13m
Sector Healthcare
Industry Health Information Services
GiC Sub-Industry Health Care Technology
IPO / Inception

PTRK Stock Ratings

Growth 5y -87.6%
Fundamental 36.2%
Dividend -
Rel. Strength Industry -1886
Analysts -
Fair Price Momentum 5.87 SEK
Fair Price DCF -

PTRK Dividends

No Dividends Paid

PTRK Growth Ratios

Growth Correlation 3m -80.3%
Growth Correlation 12m -72.6%
Growth Correlation 5y -92.7%
CAGR 5y -38.04%
CAGR/Mean DD 5y -0.64
Sharpe Ratio 12m -1.08
Alpha -56.29
Beta 0.23
Volatility 55.52%
Current Volume 12.4k
Average Volume 20d 38.3k
What is the price of PTRK stocks?
As of December 22, 2024, the stock is trading at SEK 8.52 with a total of 12,380 shares traded.
Over the past week, the price has changed by -1.15%, over one month by -4.88%, over three months by -24.41% and over the past year by -41.63%.
Is Physitrack a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Physitrack (ST:PTRK) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 36.23 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PTRK as of December 2024 is 5.87. This means that PTRK is currently overvalued and has a potential downside of -31.1%.
Is PTRK a buy, sell or hold?
Physitrack has no consensus analysts rating.
What are the forecast for PTRK stock price target?
According to ValueRays Forecast Model, PTRK Physitrack will be worth about 6.4 in December 2025. The stock is currently trading at 8.52. This means that the stock has a potential downside of -25.35%.
Issuer Forecast Upside
Wallstreet Target Price 23.1 171.4%
Analysts Target Price - -
ValueRay Target Price 6.4 -25.4%